Skip to main content
OpenTrials

Clinical trial condition

Myasthenia Gravis

Explore clinical trials studying Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

259 public trials 95 recruiting studies
Refine in advanced search Browse all conditions

Myasthenia Gravis trial results

Recruiting

A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy

NCT07595653

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis (gMG), +12 more
Locations
  • Ospedale Generale Regionale F. Miulli Acquaviva delle Fonti, Italy
  • Azienda Ospedaliero Universitaria delle Marche Ancona, Italy
  • A.O.U. Consorziale Policlinico Bari, Italy
  • ASST Papa Giovanni XXIII Bergamo, Italy
View all 30 locations
View Trial Details
Recruiting

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

NCT07526493

Conditions
Anti-Myelin Oligodendrocyte Glycoprotein Immunoglobulin G Antibody-Associated Disease (MOGAD), Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +37 more
Locations
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Recruiting

A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis.

NCT06447597

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Peking University First Hospital Beijing, China
  • The First Bethune Hospital of Jilin University Changchun, China
  • Xiangya Hospital Central South University Changsha, China
  • Sichuan Provincial People's Hospital Chengdu, China
View all 18 locations
View Trial Details
Recruiting

Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

NCT06312644

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +44 more
Locations
  • Research Site Boston, Massachusetts, United States
  • Research Site Melbourne, Victoria, Australia
  • Research Site Paris, France
  • Research Site Essen, Norte-Westfalia, Germany
View Trial Details

Related conditions